Stock RENB RENOVARO INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Renovaro Inc.

Equities

RENB

US29350E1047

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
2.02 USD -6.05% Intraday chart for Renovaro Inc. -16.53% -36.28%
Apr. 18 Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board CI
Mar. 13 Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care
GL
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board
CI
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer
CI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024
CI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
PR
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
GL
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Renovaro Inc. Announces Board Changes
CI
Sector Update: Health Care Stocks Gain Late Afternoon
MT
Sector Update: Health Care
MT
Renovaro Shares Jump After Response to Short Seller Hindenburg's Report
MT
Statement of Renovaro Inc
GL
Sector Update: Health Care Stocks Decline Late Afternoon
MT
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
BU
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RENB Stock
  4. News Renovaro Inc.